Abstract
In todays drug discovery projects, the use of virtual screening tools, either ligand-based or structure-based techniques, is gaining momentum. Taken separately, these techniques obviously present some genuine advantages on some specific tasks, for example and for a given target, it is possible to explore the local variation of the chemical space in terms of structure activity relationship (SAR), or to sample the pharmaco-topological profile of potential hit molecules in a target structure driven manner (docking). Thus, while inherent limits are associated with each of these screening techniques that are not about to be easily solved, their combination in a hybrid protocol can help to balance these limitations and capitalize on their mutual strengths. Here we review some recent studies integrating ligand- and structure-based screening protocols, and show how this concept directly benefits the quality of the hit molecules.
Keywords: Drug design, structure-based drug design, ligand-based drug design, pharmacophore, QSAR, virtual screening, combination
Current Computer-Aided Drug Design
Title: Combining Ligand- and Structure-Based Methods in Drug Design Projects
Volume: 4 Issue: 3
Author(s): Olivier Sperandio, Maria A. Miteva and Bruno O. Villoutreix
Affiliation:
Keywords: Drug design, structure-based drug design, ligand-based drug design, pharmacophore, QSAR, virtual screening, combination
Abstract: In todays drug discovery projects, the use of virtual screening tools, either ligand-based or structure-based techniques, is gaining momentum. Taken separately, these techniques obviously present some genuine advantages on some specific tasks, for example and for a given target, it is possible to explore the local variation of the chemical space in terms of structure activity relationship (SAR), or to sample the pharmaco-topological profile of potential hit molecules in a target structure driven manner (docking). Thus, while inherent limits are associated with each of these screening techniques that are not about to be easily solved, their combination in a hybrid protocol can help to balance these limitations and capitalize on their mutual strengths. Here we review some recent studies integrating ligand- and structure-based screening protocols, and show how this concept directly benefits the quality of the hit molecules.
Export Options
About this article
Cite this article as:
Sperandio Olivier, Miteva A. Maria and Villoutreix O. Bruno, Combining Ligand- and Structure-Based Methods in Drug Design Projects, Current Computer-Aided Drug Design 2008; 4 (3) . https://dx.doi.org/10.2174/157340908785747447
DOI https://dx.doi.org/10.2174/157340908785747447 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ROS Inhibitory Activity and Cytotoxicity Evaluation of Benzoyl, Acetyl, Alkyl Ester, and Sulfonate Ester Substituted Coumarin Derivatives
Medicinal Chemistry Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids
Anti-Cancer Agents in Medicinal Chemistry The GABA Transporter and its Inhibitors
Current Medicinal Chemistry Aptamer-based Emerging Tools for Viral Biomarker Detection: A Focus on SARS-CoV-2
Current Medicinal Chemistry Isolation of Antibodies From Non-Human Primates for Clinical Use
Current Drug Discovery Technologies Use of Remote Sensing Techniques for Robust Digital Change Detection of Land: A Review
Recent Patents on Space Technology Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery
Current Topics in Medicinal Chemistry In Silico Prediction Models for Blood-Brain Barrier Permeation
Current Medicinal Chemistry Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry High Content Pharmacophores from Molecular Fields: A Biologically Relevant Method for Comparing and Understanding Ligands
Current Computer-Aided Drug Design Synthesis and Antitumor Activity of Scopoletin Derivatives
Letters in Drug Design & Discovery Synthesis and Characterisation of Aminoplast Microcapsules for Controlled Release of Bioactives. Influence of the Resin:Oil Ratio
Micro and Nanosystems Coordinated Roadmap to Grip Pandemic COVID-19
Coronaviruses Suramin: Clinical Uses and Structure-Activity Relationships
Mini-Reviews in Medicinal Chemistry Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
Coronaviruses Recent Progress: Gynecologic Oncology Group Trials in Uterine Corpus Tumors
Reviews on Recent Clinical Trials Synthesis of a 2, 4, 8-Trisubstituted Pyrimidino[5, 4-d]Pyrimidine Library via Sequential SNAr Reactions on Solid-Phase
Combinatorial Chemistry & High Throughput Screening Cannabinoid Type 2 Receptor as a Target for Chronic - Pain
Mini-Reviews in Medicinal Chemistry Recovery of a 91-year-old COVID-19 Patient with Medical and Psychological Support
Current Chinese Science Selective Estrogen Receptor Modulator Medicinal Chemistry At Merck. A Review
Current Topics in Medicinal Chemistry